LWEL — Luckwel Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
FinancialsHighly SpeculativeMicro Cap
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | — | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.451 | 0.537 | 0.623 | 0.536 | 0.435 |
Operating Profit | -0.451 | -0.537 | -0.623 | -0.536 | -0.435 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.511 | -0.537 | -0.623 | -0.536 | -0.436 |
Net Income After Taxes | -0.511 | -0.537 | -0.623 | -0.536 | -0.436 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.511 | -0.537 | -0.623 | -0.536 | -0.436 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.511 | -0.537 | -0.623 | -0.536 | -0.436 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.029 | -0.029 | -0.005 | -0.004 | -0.003 |